During the past decade, Kishiwada Tokushukai Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 15 clinical trials were completed, i.e. on average, 78.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 12 clinical trials were completed. i.e. 171.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kishiwada Tokushukai Hospital" #1 sponsor was "Bayer" with 9 trials, followed by "Boston Scientific Corporation" with 4 trials sponsored, "Janssen Pharmaceutical K.K." with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kishiwada Tokushukai Hospital" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Association for Establishment of Ebvidence in Interventions" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Kishiwada Tokushukai Hospital" are "Heart Failure" (4 trials), "Atrial Fibrillation" (2 trials), "Peripheral Arterial Disease" (2 trials), "Acute Myocardial Infarction" (1 trials) and "Arterial Occlusive Disease" (1 trials). Many other conditions were trialed in "Kishiwada Tokushukai Hospital" in a lesser frequency.

Most popular intervention types in "Kishiwada Tokushukai Hospital" are "Drug" (16 trials), "Device" (8 trials), "Other" (4 trials), "Biological" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Apixaban" (2 trials), "Apixaban matching placebo" (2 trials), "BAY2433334" (2 trials) and "BAY2433334 matching placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kishiwada Tokushukai Hospital" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Kishiwada Tokushukai Hospital". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Kishiwada Tokushukai Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kishiwada Tokushukai Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".